İ. ŞAHİN Et Al. , "Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins," ENDOCRINE REVIEWS , vol.35, no.3, 2014
ŞAHİN, İ. Et Al. 2014. Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins. ENDOCRINE REVIEWS , vol.35, no.3 .
ŞAHİN, İ., Karaca, Z., Taskapan, C., Ozyalin, F., & YOLOĞLU, S., (2014). Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins. ENDOCRINE REVIEWS , vol.35, no.3.
ŞAHİN, İBRAHİM Et Al. "Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins," ENDOCRINE REVIEWS , vol.35, no.3, 2014
ŞAHİN, İBRAHİM Et Al. "Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins." ENDOCRINE REVIEWS , vol.35, no.3, 2014
ŞAHİN, İ. Et Al. (2014) . "Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins." ENDOCRINE REVIEWS , vol.35, no.3.
@article{article, author={İBRAHİM ŞAHİN Et Al. }, title={Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins}, journal={ENDOCRINE REVIEWS}, year=2014}